Significant Ownership of Steven Michael Oliveira
- Signature - Title
- /s/ Oliveira Steven Michael - Individual
- Location
- New City, NY
- Summary
- This page shows a list of all the recent SCHEDULE 13D/G filings made by Steven Michael Oliveira.
Follow Filing Activity
Follow Steven Michael Oliveira and return when a new Schedule 13D/G filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
Useful next steps after a schedule filing
Use the page below that answers the next obvious question about this reporting manager or security.
- Latest 13D/G reports to compare this manager with other current ownership disclosures.
- Latest insider ownership reports if you want insider activity alongside the beneficial ownership record.
- Latest 13F portfolio filings for broader institutional context.
- Latest investment quarter holder pages when the next step is security-level holder history.
Significant Ownership of Steven Michael Oliveira
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| ATHA | Athira Pharma, Inc. | Common Stock | 4.1% | $69,324 | -$788,375 | 161,218 | -92% | Oliveira Steven Michael | 01 Oct 2025 |
| FBRX | Forte Biosciences, Inc. | Common Stock, $0.001 par value | 2.4% | $6,797,265 | -$2,993,786 | 300,100 | -31% | Oliveira Steven Michael | 08 Jan 2026 |
Schedules 13D/G Reported by Steven Michael Oliveira:
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.